These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30769941)

  • 1. The Contribution of Pluripotent Stem Cell (PSC)-Based Models to the Study of Fragile X Syndrome (FXS).
    Abu Diab M; Eiges R
    Brain Sci; 2019 Feb; 9(2):. PubMed ID: 30769941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling Fragile X Syndrome Using Human Pluripotent Stem Cells.
    Mor-Shaked H; Eiges R
    Genes (Basel); 2016 Sep; 7(10):. PubMed ID: 27690107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic modifications in human fragile X pluripotent stem cells; Implications in fragile X syndrome modeling.
    Gerhardt J
    Brain Res; 2017 Feb; 1656():55-62. PubMed ID: 26475977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CGG-repeat dynamics and
    Zhou Y; Kumari D; Sciascia N; Usdin K
    Mol Autism; 2016; 7():42. PubMed ID: 27713816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reevaluation of
    Mor-Shaked H; Eiges R
    Front Mol Neurosci; 2018; 11():31. PubMed ID: 29467618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CGG Repeat-Induced FMR1 Silencing Depends on the Expansion Size in Human iPSCs and Neurons Carrying Unmethylated Full Mutations.
    Brykczynska U; Pecho-Vrieseling E; Thiemeyer A; Klein J; Fruh I; Doll T; Manneville C; Fuchs S; Iazeolla M; Beibel M; Roma G; Naumann U; Kelley N; Oakeley EJ; Mueller M; Gomez-Mancilla B; Bühler M; Tabolacci E; Chiurazzi P; Neri G; Bouwmeester T; Di Giorgio FP; Fodor BD
    Stem Cell Reports; 2016 Dec; 7(6):1059-1071. PubMed ID: 27840045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Throughput Screening to Identify Compounds That Increase Fragile X Mental Retardation Protein Expression in Neural Stem Cells Differentiated From Fragile X Syndrome Patient-Derived Induced Pluripotent Stem Cells.
    Kumari D; Swaroop M; Southall N; Huang W; Zheng W; Usdin K
    Stem Cells Transl Med; 2015 Jul; 4(7):800-8. PubMed ID: 25999519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human pluripotent stem cell models of Fragile X syndrome.
    Bhattacharyya A; Zhao X
    Mol Cell Neurosci; 2016 Jun; 73():43-51. PubMed ID: 26640241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivation of FMR1 by CRISPR/Cas9-Mediated Deletion of the Expanded CGG-Repeat of the Fragile X Chromosome.
    Xie N; Gong H; Suhl JA; Chopra P; Wang T; Warren ST
    PLoS One; 2016; 11(10):e0165499. PubMed ID: 27768763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNAs and Fragile X Syndrome.
    Lin SL
    Adv Exp Med Biol; 2015; 888():107-21. PubMed ID: 26663181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversion of FMR1 Methylation and Silencing by Editing the Triplet Repeats in Fragile X iPSC-Derived Neurons.
    Park CY; Halevy T; Lee DR; Sung JJ; Lee JS; Yanuka O; Benvenisty N; Kim DW
    Cell Rep; 2015 Oct; 13(2):234-41. PubMed ID: 26440889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FMR1 epigenetic silencing commonly occurs in undifferentiated fragile X-affected embryonic stem cells.
    Avitzour M; Mor-Shaked H; Yanovsky-Dagan S; Aharoni S; Altarescu G; Renbaum P; Eldar-Geva T; Schonberger O; Levy-Lahad E; Epsztejn-Litman S; Eiges R
    Stem Cell Reports; 2014 Nov; 3(5):699-706. PubMed ID: 25418717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The FMR1 promoter is selectively hydroxymethylated in primary neurons of fragile X syndrome patients.
    Esanov R; Andrade NS; Bennison S; Wahlestedt C; Zeier Z
    Hum Mol Genet; 2016 Nov; 25(22):4870-4880. PubMed ID: 28173181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetics of fragile X syndrome and fragile X-related disorders.
    Kraan CM; Godler DE; Amor DJ
    Dev Med Child Neurol; 2019 Feb; 61(2):121-127. PubMed ID: 30084485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FMR1 CGG repeat lengths mediate different regulation of reporter gene expression in comparative transient and locus specific integration assays.
    Sølvsten C; Nielsen AL
    Gene; 2011 Oct; 486(1-2):15-22. PubMed ID: 21767618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal Diagnosis of Fragile X Syndrome in a Twin Pregnancy Complicated by a Complete Retraction.
    Prawer Y; Hunter M; Cronin S; Ling L; Aliaga Vera S; Fahey M; Gelfand N; Oertel R; Bartlett E; Francis D; Godler D
    Genes (Basel); 2018 Jun; 9(6):. PubMed ID: 29880767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reciprocal changes in DNA methylation and hydroxymethylation and a broad repressive epigenetic switch characterize FMR1 transcriptional silencing in fragile X syndrome.
    Brasa S; Mueller A; Jacquemont S; Hahne F; Rozenberg I; Peters T; He Y; McCormack C; Gasparini F; Chibout SD; Grenet O; Moggs J; Gomez-Mancilla B; Terranova R
    Clin Epigenetics; 2016; 8():15. PubMed ID: 26855684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated Fmr1 mRNA levels and reduced protein expression in a mouse model with an unmethylated Fragile X full mutation.
    Brouwer JR; Mientjes EJ; Bakker CE; Nieuwenhuizen IM; Severijnen LA; Van der Linde HC; Nelson DL; Oostra BA; Willemsen R
    Exp Cell Res; 2007 Jan; 313(2):244-53. PubMed ID: 17150213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of CGG repeat instability in germline cells from two male fetuses affected with fragile X syndrome].
    Duan R; Luo S; Huang W; Li H; Peng Y; Du Q; Wu L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Oct; 33(5):606-9. PubMed ID: 27577204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between IQ and FMR1 protein (FMRP) across the spectrum of CGG repeat expansions.
    Kim K; Hessl D; Randol JL; Espinal GM; Schneider A; Protic D; Aydin EY; Hagerman RJ; Hagerman PJ
    PLoS One; 2019; 14(12):e0226811. PubMed ID: 31891607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.